Document is current

Article History

Accepted: 18 June 2023

First Online: 18 July 2023

Declarations

:

: This study did not receive any funding.

: AM declares financial interest and a position on the advisory board of Fig. 1 Beauty, Inc., Eli Lilly and Company, Pfizer Inc., and Hims. AM receives fees as a consultant from AbbVie, Concert Pharmaceuticals, Pfizer Inc., and 3Derm Systems. AM is the founder of Lucid, Inc. and receives research funding from Incyte Corporation, Aclaris Therapeutics Inc., Eli Lilly and Company and Concert Pharmaceuticals. All other authors declare no conflict of interest.

: Not applicable.

: Not applicable.

: No datasets were generated or analyzed for the current study.

: Not applicable.

: All authors contributed to the study design. The search strategy development and literature search were performed by S.L., C.M, and A.M. Data collection and interpretation were conducted by S.L., P.M., K.K., A.S., B.W., N.A., L.D., K.S., S.G., and A.M. Statistical analysis was performed by S.L. and G.Z. The manuscript was drafted by S.L. and critically revised by all other authors. All authors read and approved the final manuscript.